Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen-specific tumor cell killing by cytotoxic T cells

• Published in: eLife 2023-09, Vol.12
• Main Authors: Herzfeldt, Ann-Kathrin, Gamez, Marta Puig, Martin, Eva, Boryn, Lukasz Miloslaw, Baskaran, Praveen, Huber, Heinrich J, Schuler, Michael, Park, John E, Swee, Lee Kim
• Format: Article
• Language: English
• Subjects: Antigen presentation; Autophagy; Cancer Biology; cancer immunology; Cancer immunotherapy; CD8 antigen; Cell culture; Cells; CRISPR; CRISPR KO screen; CRISPRa screen; Cytomegalovirus; cytotoxic T cells; Cytotoxicity; Gene expression; Genetics and Genomics; ICAM-1; Immunological synapses; Intercellular adhesion molecule 1; Lymphocytes; Lymphocytes T; Melanoma; PD-L1 protein; Peptides; Protein-serine/threonine phosphatase; Threonine phosphatase; tumor cell killing; Tumor cells; Tumor necrosis factor-α; Tumors; γ-Interferon
• ISSN: 2050-084X; 2050-084X
• DOI: 10.7554/eLife.84314

Cytotoxic CD8 +T lymphocytes (CTLs) are key players of adaptive anti-tumor immunity based on their ability to specifically recognize and destroy tumor cells. Many cancer immunotherapies rely on unleashing CTL function. However, tumors can evade killing through strategies which are not yet fully elucidated. To provide deeper insight into tumor evasion mechanisms in an antigen-dependent manner, we established a human co-culture system composed of tumor and primary immune cells. Using this system, we systematically investigated intrinsic regulators of tumor resistance by conducting a complementary CRISPR screen approach. By harnessing CRISPR activation (CRISPRa) and CRISPR knockout (KO) technology in parallel, we investigated gene gain-of-function as well as loss-of-function across genes with annotated function in a colon carcinoma cell line. CRISPRa and CRISPR KO screens uncovered 187 and 704 hits, respectively, with 60 gene hits overlapping between both. These data confirmed the role of interferon-γ (IFN-γ), tumor necrosis factor α (TNF-α) and autophagy pathways and uncovered novel genes implicated in tumor resistance to killing. Notably, we discovered that ILKAP encoding the integrin-linked kinase-associated serine/threonine phosphatase 2 C, a gene previously unknown to play a role in antigen specific CTL-mediated killing, mediate tumor resistance independently from regulating antigen presentation, IFN-γ or TNF-α responsiveness. Moreover, our work describes the contrasting role of soluble and membrane-bound ICAM-1 in regulating tumor cell killing. The deficiency of membrane-bound ICAM-1 (mICAM-1) or the overexpression of soluble ICAM-1 (sICAM-1) induced resistance to CTL killing, whereas PD-L1 overexpression had no impact. These results highlight the essential role of ICAM-1 at the immunological synapse between tumor and CTL and the antagonist function of sICAM-1.